Drug Shortage Report for APO-GUANFACINE XR

Last updated on 2025-01-17 History
Report ID 245499
Drug Identification Number 02523744
Brand name APO-GUANFACINE XR
Common or Proper name GUANFACINE XR
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GUANFACINE
Strength(s) 3MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30 BTL
ATC code C02AC
ATC description ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-10
Estimated end date 2025-01-17
Actual end date 2025-01-16
Shortage status Resolved
Updated date 2025-01-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-01-17 French Compare
v5 2025-01-17 English Compare
v4 2025-01-02 French Compare
v3 2025-01-02 English Compare
v2 2024-12-12 French Compare
v1 2024-12-12 English Compare

Showing 1 to 6 of 6